pathology

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

The Duke BioRepository & Precision Pathology Center, a Duke School of Medicine Service Center and DCI Shared Resource turns 10.

Learn about new developments in next generation molecular sequencing tests at the DUHS Clinical Labs' Clinical Molecular Diagnostics Laboratory.

DCI pathologist Jeffrey Marks, PhD, has been named "Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery."

Furong Huang PhD, a postdoctoral fellow in the Wang Lab, received a Department of Defense Prostate Cancer Research Program Early Investigator Award.

DCI faculty Drs. Sullivan, Johnson, Devi, and Kirsch recognized by the SoM for teaching, mentoring, and new faculty member Dr. Shi named Whitehead Scholar.

Ken Young, MD, PhD, will assume the role of chief, Hematopathology Division and DCI Blood Cancer Pathology Service, on Jan. 1, 2021.

NCI welcomes the Duke BioRepository & Precision Pathology Center as the new site of the Southern Division of the Cooperative Human Tissue Network.

The Duke Department of Pathology/Duke Clinical Labs has established the Division of Artificial Intelligence and Computational Pathology.

Duke researchers are using a $200,000 grant from NC Biotech to “supercharge” vital medical information.

DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.